Mostafa Kamal Joins Prime Therapeutics as President: Ready to Accelerate Growth and Innovation

Prime Therapeutics LLC (Prime), a pharmacy benefit manager serving nearly 38 million members nationwide, is thrilled to announce the appointment of Mostafa Kamal as president of the organization. Kamal also holds the position of CEO of Magellan Rx, a company that Prime acquired in December 2022. With the addition of Kamal to the leadership team, Ken Paulus will remain in his current role as CEO of Prime.

Kamal has been promoted to President at Prime, taking on an expanded role with overall responsibility for all of Magellan Rx’s lines of business, Prime’s specialty pharmacy solutions, pharmacy benefit management solutions, enterprise marketing and communications, and enterprise operations and technology. His impressive background and experience make him the perfect fit to lead Prime into the future.

I’m thrilled to be at the helm of our newly merged organization as we strive to create a pharmacy solutions company that is centered around affordability and improved access to vital medicines. I’d like to thank Ken and the entire leadership team at Prime for their unwavering dedication to driving the industry forward. Together, we can create a different and better future for our members, providers, and patients.

Kamal has been a driving force in the healthcare industry since 2015, when he assumed the role of CEO of Magellan Rx. He has leveraged his extensive experience with Magellan Rx and Medco Health Solutions, Inc. (now Express Scripts) to spearhead the organization’s success. Kamal is a proud Rutgers University graduate, having earned his Bachelor of Science degree in economics from New Brunswick, New Jersey.

About Prime Therapeutics + Magellan Rx

At Prime Therapeutics LLC, we are pioneering the way in healthcare with our diversified pharmacy solutions. We are proudly collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries, and affiliates, and through the combined efforts of our team and Magellan Rx Management, a Prime Therapeutics LLC Company, we are leading the way in specialty and medical drug management and serving public sector state government programs.

Our solutions bridge the distance between medical and pharmacy management, providing our clients with the highest quality of care.

Leave a Comment